Tapentadol is an opioid pain medicine. It may be prescribed when the pain and treatment options justify using an opioid, but it can cause dependence, dangerous breathing suppression, overdose, and death. Take only the prescribed medicine and arrange regular reviews of its benefits and risks. [2]
What tapentadol does and when it is used
Tapentadol acts at mu-opioid receptors and reduces the reuptake of norepinephrine, both of which contribute to its pain-relieving effect. Palexia is one brand name. [1]
Immediate-release and extended-release products have different directions. In the United States, Nucynta tablets treat acute pain severe enough to require an opioid when alternatives are inadequate. Nucynta ER treats severe, persistent pain requiring extended treatment when alternatives, including immediate-release opioids, are inadequate. It is not an as-needed medicine. [2], [3]
Approved uses and age limits differ by country, formulation, and sometimes body weight. Some products have pediatric indications, while others are for adults. A child’s treatment must follow the exact local product information and an individual prescribing plan. [4], [15]
Ask what improvement in pain and everyday functioning is expected, which nonopioid treatments may help, and when treatment will be reviewed or ended. New or worsening pain needs reassessment, rather than an automatic dose increase. Opioids can sometimes increase sensitivity to pain. [7], [2]
An approved indication does not make a medicine the preferred treatment. Although US Nucynta ER labeling includes painful diabetic peripheral neuropathy, the American Academy of Neurology’s guideline advises against tapentadol and other opioids for this condition. Discuss alternatives with the prescriber; do not abruptly stop existing treatment. [3], [13]
Taking the prescribed product safely
Do not take extra doses, share the prescription, or change formulations yourself. Measure a prescribed liquid with the supplied oral syringe or another device recommended by the pharmacist, never a household spoon. Keep the medicine secure and out of children’s reach; ask a pharmacist about safe disposal. [5]
Palexia prolonged-release tablets and Nucynta ER must be swallowed whole, without dividing, chewing, or crushing. Altering them can release the medicine too quickly. Check the exact product instructions with a pharmacist instead of assuming every tapentadol tablet has the same handling rules. [4], [3]
Tell the prescriber about breathing problems or sleep apnea, bowel blockage, seizures or head injury, liver or kidney disease, and all other medicines. Some conditions rule out treatment or require a different plan. Do not convert between opioids using an internet calculation. [2]
Pregnancy and breastfeeding require prompt advice from the prescriber. Longer opioid use during pregnancy can cause newborn withdrawal, and use around delivery can suppress the baby’s breathing. The German Palexia retard leaflet says it must not be taken while breastfeeding. Plan any treatment change with the clinician rather than stopping suddenly yourself. [15], [9]
Side effects and important interactions
Nausea, vomiting, constipation, dizziness, and sleepiness can occur. Ask about persistent or troublesome effects and constipation prevention. Do not drive or operate machinery while drowsy or impaired. Sleepiness or constipation alone does not establish an addiction. [3], [8]
Seek emergency help for slow or shallow breathing, inability to wake, collapse, a seizure, or swelling of the face or throat with breathing difficulty. These are different from routine mild side effects. If breathing or consciousness is affected, do not wait for a routine appointment. [5]
Avoid alcohol. Benzodiazepines, sleeping medicines, other opioids, and other sedating drugs can intensify sedation and breathing suppression; gabapentin and pregabalin also increase this risk. Have the prescriber or pharmacist review all combinations. A half-life estimate cannot establish a safe drinking interval. [1]
Tapentadol can provoke seizures, with additional risk from medicines that lower the seizure threshold. Serotonin syndrome has been reported with serotonergic medicines, including some antidepressants. Agitation with fever, sweating, tremor, or muscle stiffness needs urgent assessment. Tell the prescriber about current or recent monoamine oxidase inhibitor use; this combination must be avoided under the product’s instructions. [6]
Dependence, opioid use disorder, and withdrawal
Physical dependence means the body has adapted and withdrawal may occur after a reduction or abrupt stop. Tolerance means the same amount has less effect over time. Neither alone establishes opioid use disorder. A broader pattern, such as difficulty controlling use, strong cravings, or continued use despite harm, warrants professional assessment. Tolerance and withdrawal alone are not counted as opioid use disorder criteria during appropriate medical treatment. [8]
After repeated use, stopping usually needs a gradual, individualized plan. Agree on follow-up, whom to contact, and how pain will continue to be treated. The pace may need adjustment if withdrawal becomes difficult. Serious adverse effects can require urgent medical changes; do not delay emergency help in order to follow a routine taper. [9]
Withdrawal may include restlessness, sweating, sleep difficulty, runny nose, aches, nausea, vomiting, or diarrhea. Timing and severity vary. Tell the clinician about symptoms during a reduction instead of assuming that every symptom is withdrawal. [5]
If opioid use disorder is identified, evidence-based treatment can include medication and continuing support. Withdrawal management alone is not a complete treatment for opioid use disorder and can increase later overdose risk without ongoing treatment. Seek assessment while still taking the medicine; pain care and addiction care should be coordinated. [10]
Suspected overdose: get help immediately
An opioid overdose can be fatal. Call the local emergency number immediately if the person is unresponsive or breathing slowly or shallowly. Give available naloxone according to its instructions and stay with the person until help arrives. Repeat administration may be needed. Naloxone is temporary, so emergency assessment is still necessary even if the person wakes up. [11]
For suspected poisoning, seek immediate medical advice even before symptoms appear. If unconscious but breathing normally, place the person on their side. If unresponsive and not breathing normally, follow the dispatcher’s CPR instructions. Do not induce vomiting or give anything to eat or drink. Keep the medicine packaging for responders. [12]
YOU MAY FIND THESE HELPFUL
A useful place to start.
Private Opioid Addiction Treatment & Rehab
ExploreRead & learnCo-codamol: Ingredients, Side Effects and Safe Use
ExploreRead & learnBuprenorphine
ExploreAssessment & Treatment Planning
ExplorePlan your stayHow Admission Works
ExploreUnderstandPrivate Opioid Addiction Treatment & Rehab
ExploreQuestions
Frequently Asked Questions
Is Palexia the same as tapentadol?
Palexia contains tapentadol. The brand name alone does not identify the release formulation or instructions, so check the full product name and prescription. [1]
Is tapentadol the same as tramadol?
No. Both are opioid pain medicines, but they are different drugs. Do not substitute one for the other or assume one is automatically safer. A switch requires a prescriber’s assessment of the exact products and your circumstances. [14], [1]
Can I use tapentadol as a sleeping pill?
No. It is a pain medicine, and sleepiness is an adverse effect. Taking it to induce sleep can expose you to dangerous sedation and breathing problems. [5]
Can I stop tapentadol suddenly?
After repeated use, sudden stopping can cause withdrawal. Ask the prescriber for an individual reduction plan. Severe breathing problems, inability to wake, or other serious reactions need emergency help, not a self-managed taper. [9]
Does physical dependence mean I have an addiction?
No. Physical dependence can develop during prescribed treatment. Opioid use disorder involves a broader pattern that needs assessment, including impaired control or continued use despite harm. Discuss concerns openly with a clinician. [8]
Editorial evidence
Evidence & sources
Selected clinical guidelines, peer-reviewed research, and public-health sources used in this article.
View all 15 sourcesShow fewer sources
Clinical context
Clear information is framed around complex and co-occurring presentations.
Individual factors
Assessment remains essential because needs and risks differ from person to person.
Next steps
A confidential conversation can help clarify the most appropriate route forward.
Not sure where the situation fits?
Your admissions team


A confidential first conversation can help clarify the presentation and whether our setting is appropriate.
